The ARUBA study concluded that unruptured brain arteriovenous malformations (AVM) should only be treated medically. Were these conclusions limited by the study’s design? Are there cases today where an endovascular approach could prove safe, effective and clinically warranted?
Join Professors Jacques Moret and Laurent Spelle as they illustrate the management of unruptured AVMs through specially chosen cases. With their expert panel, join them as they examine the full range of clinical options, looking beyond medical therapy to endovascular, surgical or radiosurgical approaches.
Consider such points in managing unruptured AVMs as: